We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Oxford Biomedica | AQSE:OXB.GB | Aquis Stock Exchange | Ordinary Share | GB00BDFBVT43 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 10.00 | 3.35% | 308.50 | 300.00 | 317.00 | 308.50 | 298.50 | 298.50 | 0.00 | 08:20:57 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
TIDMOXB
RNS Number : 2617Y
Oxford Biomedica PLC
02 January 2024
Hot Features
Premium
Name of applicant: OXFORD BIOMEDICA PLC
Name of scheme: 2015 Employee Share Option Scheme
--------------------------------------
Period of return: From: 1 July 2023 To: 31 December 2023
----------- ------------- ---- -----------------
Balance of unallotted securities
under scheme(s) from previous
return: 309,426
--------------------------------------
Plus: The amount by which the NIL
block scheme(s) has been increased
since the date of the last return
(if any increase has been applied
for):
--------------------------------------
Less: Number of securities issued/allotted
under scheme(s) during period
(see LR3.5.7G): 2,905
--------------------------------------
Equals: Balance under scheme(s)
not yet issued/allotted at end
of period: 306,521
--------------------------------------
Name of applicant: OXFORD BIOMEDICA PLC
Name of scheme: 2015 Long Term Incentive Plan
-------------------------------------
Period of return: From: 1 July 2023 To: 31 December 2023
----------- ------------ ---- -----------------
Balance of unallotted securities
under scheme(s) from previous
return: 442,977
-------------------------------------
Plus: The amount by which the NIL
block scheme(s) has been increased
since the date of the last return
(if any increase has been applied
for):
-------------------------------------
Less: Number of securities issued/allotted
under scheme(s) during period
(see LR3.5.7G): 192,609
-------------------------------------
Equals: Balance under scheme(s)
not yet issued/allotted at end
of period: 250,368
-------------------------------------
Name of applicant: OXFORD BIOMEDICA PLC
Name of scheme: 2015 Deferred Bonus Plan
-------------------------------------
Period of return: From: 1 July 2023 To: 31 December 2023
----------- ------------ ---- -----------------
Balance of unallotted securities
under scheme(s) from previous
return: 296,272
-------------------------------------
Plus: The amount by which the NIL
block scheme(s) has been increased
since the date of the last return
(if any increase has been applied
for):
-------------------------------------
Less: Number of securities issued/allotted
under scheme(s) during period
(see LR3.5.7G): 28,200
-------------------------------------
Equals: Balance under scheme(s)
not yet issued/allotted at end
of period: 268,072
-------------------------------------
Name of applicant: OXFORD BIOMEDICA PLC
Name of scheme: Sharesave Scheme
-------------------------------------
Period of return: From: 1 July 2023 To: 31 December 2023
------------ ------------ ---- -----------------
Balance of unallotted securities
under scheme(s) from previous
return: 339,753
-------------------------------------
Plus: The amount by which the NIL
block scheme(s) has been increased
since the date of the last return
(if any increase has been applied
for):
-------------------------------------
Less: Number of securities issued/allotted NIL
under scheme(s) during period
(see LR3.5.7G):
-------------------------------------
Equals: Balance under scheme(s)
not yet issued/allotted at end
of period: 339,753
-------------------------------------
Name of contact: Natalie Walter, Company Secretary
Telephone number of contact: 01865 783000
----------------------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
BLRTLBFTMTITBBJ
(END) Dow Jones Newswires
January 02, 2024 02:00 ET (07:00 GMT)
1 Year Oxford Biomedica Chart |
1 Month Oxford Biomedica Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
